Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows an updated software release/revision identifier (“Revision: v3.5.3”) instead of the previous one (“Revision: v3.5.2”). This reflects a site version update rather than a change to the clinical study details.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded Revision: v3.5.2. Removed Revision: v3.5.0.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange Detected- Revision updated to v3.5.0, replacing the previous v3.4.3. - This appears to be a software/update change with no visible edits to study details or user-facing content.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check84 days agoChange DetectedMinimal site update detected: Revision: v3.4.2 was added and the government funding lapse notice was removed. No changes were made to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedAdded a government funding notice about potential delays in updating information and site operations. Updated the site revision tag to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.